References
Stein H, Harris N, Campo E (2008) Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon, pp 127–129
Castillo JA, Reagan JL (2011) Plasmablastic lymphoma: a systemic review. Sci World J 11:687–696
Wong AK, Kerkoutian S, Pullarkat ST (2012) Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studies. Clin Rheumatol 31:631–636
Siegel CA, Marden SM, Persing SM, Larson RJ, Sands BE (2009) Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn’s disease: a meta-analysis. Clin Gastroenterol Hepatol 7:874–881
Biancone L, Zuzzi S, Pallone F et al (2012) Fistulising pattern in Crohn’s disease and pan colitis in ulcerative colitis are independent risk factors for cancer: a single-centre cohort study. J Crohn's Colitis 6:578–587
Redmond M, Quinn J, Murphy P, Leader M (2007) Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn’s disease after immunosuppressive therapy. J Clin Pathol 60:80–81
Luria L, Nguyen J, Zhang L et al (2014) Manifestations of gastrointestinal plasmablastic lymphoma: a case series with literature review. World J Gastroenterol 20:11894–11903
Conflict of interest
The authors do not have any conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maung, S.W., Desmond, R., McHugh, J. et al. A coincidence or a rare occurrence? A case of plasmablastic lymphoma of the small intestines following infliximab treatment for Crohn’s disease. Ann Hematol 95, 149–150 (2016). https://doi.org/10.1007/s00277-015-2497-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-015-2497-6